LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma

Medical Oncology

Volumn 33, Issue 8, 2016, Pages

  Wei, Yanping ^a   Sun, Qianqian ^b   Zhao, Lindong ^a   Wu, Jianbo ^b   Chen, Xiaonan ^b   Wang, Yuanyuan ^b   Zang, Wenqiao ^b   Zhao, Guoqiang ^b,c  

^a The People s Hospital of Jiaozuo City   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c Department of Respiratory Diseases and Clinical Medicine   (China)

Author keywords

FOXM1; LncRNA UCA1; Melanoma; miR 507

Indexed keywords

FOXM1 PROTEIN; LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 507; PROTEIN; UCA1 PROTEIN; UNCLASSIFIED DRUG; FORKHEAD BOX PROTEIN M1; FOXM1 PROTEIN, HUMAN; UCA1 RNA, HUMAN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; METASTATIC MELANOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; UPREGULATION; CELL CYCLE CHECKPOINT; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOPRECIPITATION; MELANOMA; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; TUMOR INVASION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; FLOW CYTOMETRY; FORKHEAD BOX PROTEIN M1; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; MELANOMA; MICRORNAS; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; TRANSFECTION;

EID: 84978153415     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-016-0804-2     Document Type: Article

References (23)

1. Aladowicz E, Ferro L, Vitali GC, Venditti E, Fornasari L, Lanfrancone L. Molecular networks in melanoma invasion and metastasis. Future Oncol. 2013;9(5):713–26.
2. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21.
3. Weinstein D, Leininger J, Hamby C, Safai B. Diagnostic and prognostic biomarkers in melanoma. J Clin Aesthet Dermatol. 2014;7(6):13–24.
4. Cao B, Song N, Zhang M, Di C, Yang Y, Lu Y, et al. Systematic study of novel lncRNAs in different gastrointestinal cancer cells. Discov Med. 2016;21(115):159–71.
5. Sand M, Bechara FG, Sand D, Gambichler T, Hahn SA, Bromba M, et al. Expression profiles of long noncoding RNAs in cutaneous squamous cell carcinoma. Epigenomics. 2016;8(4):501–18.
6. Deng W, Wang J, Zhang J, Cai J, Bai Z, Zhang Z. TET2 regulates LncRNA-ANRIL expression and inhibits the growth of human gastric cancer cells. IUBMB Life. 2016;68(5):355–64.
7. Tian Y, Zhang X, Hao Y, Fang Z, He Y. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res. 2014;24(4):335–41.
8. Yamamoto S, Inoue J, Kawano T, Kozaki K, Omura K, Inazawa J. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors. Mol Cancer Res. 2014;12(1):58–68.
9. Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29(4):452–63.
10. Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu Y, et al. LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep. 2016;6(23892):9.
11. Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.
12. Li Y, Wang T, Li Y, Chen D, Yu Z, Jin L, et al. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma. Mol Med Rep. 2016;13(4):3326–34.
13. Nie W, Ge HJ, Yang XQ, Sun X, Huang H, Tao X, et al. LncRNA-UCA1exerts oncogenic functions in non-small cell lungcancerby targeting miR-193a-3p. Cancer Lett. 2016;371(1):99–106.
14. Hughes JM, Legnini I, Salvatori B, Masciarelli S, Marchioni M, Fazi F, et al. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia. Oncotarget. 2015;6(21):18534–44.
15. Wang Y, Hou J, He D, Sun M, Zhang P, Yu Y, et al. The emerging function and mechanism of ceRNAs in Cancer. Trends Genet. 2016;32(4):211–24.
16. Tuo YL, Li XM, Luo J. Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143. Eur Rev Med Pharmacol Sci. 2015;19(18):3403–11.
17. Myatt SS, Kongsema M, Man CW, Kelly DJ, Gomes AR, Khongkow P, et al. SUMOylation inhibits FOXM1 activity and delays mitotic transition. Oncogene. 2014;33(34):4316–29.
18. Sun Y, Yu X, Bai Q. miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer. Int J Clin Exp Pathol. 2015;8(10):12775–83.
19. Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei K, et al. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Oncotarget. 2016;7(1):293–307.
20. Yuan F, Wang W. MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1. Mol Med Rep. 2015;12(3):4647–51.
21. Ito T, Kohashi K, Yamada Y, Maekawa A, Kuda M, Furue M, et al. Prognostic significance of Forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in melanoma. Histopathology. 2016;69(1):63–71.
22. Miyashita A, Fukushima S, Nakahara S, Yamashita J, Tokuzumi A, Aoi J, et al. Investigation of FOXM1 as a potential new target for melanoma. Plos One. 2015;10(12):e0144241.
23. Sarkar D, Leung EY, Baguley BC, Finlay GJ, Askarian-Amiri ME. Epigenetic regulation in human melanoma: past and future. Epigenetics. 2015;10(2):103–21.